ReviewTherapeutics and clinical risk management2023

Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection - A Narrative Review.

Claudia Altamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.